Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.
Identifieur interne : 002F56 ( PubMed/Curation ); précédent : 002F55; suivant : 002F57Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.
Auteurs : Chandrakant Lahariya [Inde] ; Ashok MishraSource :
- Journal of vector borne diseases [ 0972-9062 ] ; 2008.
Descripteurs français
- KwdFr :
- Adulte, Agents de santé communautaire (enseignement et éducation), Calendrier d'administration des médicaments, Collecte de données, Comprimés, Connaissances, attitudes et pratiques en santé, Diéthylcarbamazine (administration et posologie), Diéthylcarbamazine (effets indésirables), Diéthylcarbamazine (ressources et distribution), Enfant, Filaricides (administration et posologie), Filaricides (effets indésirables), Filaricides (ressources et distribution), Filariose lymphatique (), Filariose lymphatique (traitement médicamenteux), Filariose lymphatique (économie), Humains, Inde (épidémiologie), Innovation organisationnelle, Mise au point de programmes, Mise en oeuvre des programmes de santé, Observance du traitement médicamenteux (), Participation communautaire, Services de santé communautaires (main d’œuvre), Services de santé communautaires (organisation et administration), Systèmes de distribution des médicaments (organisation et administration), Éducation pour la santé (), Éducation pour la santé (économie), Études transversales.
- MESH :
- administration et posologie : Diéthylcarbamazine, Filaricides.
- effets indésirables : Diéthylcarbamazine, Filaricides.
- enseignement et éducation : Agents de santé communautaire.
- main d’œuvre : Services de santé communautaires.
- organisation et administration : Services de santé communautaires, Systèmes de distribution des médicaments.
- ressources et distribution : Diéthylcarbamazine, Filaricides.
- traitement médicamenteux : Filariose lymphatique.
- économie : Filariose lymphatique, Éducation pour la santé.
- épidémiologie : Inde.
- Adulte, Calendrier d'administration des médicaments, Collecte de données, Comprimés, Connaissances, attitudes et pratiques en santé, Enfant, Filariose lymphatique, Humains, Innovation organisationnelle, Mise au point de programmes, Mise en oeuvre des programmes de santé, Observance du traitement médicamenteux, Participation communautaire, Éducation pour la santé, Études transversales.
English descriptors
- KwdEn :
- Adult, Child, Community Health Services (manpower), Community Health Services (organization & administration), Community Health Workers (education), Community Participation, Cross-Sectional Studies, Data Collection, Diethylcarbamazine (administration & dosage), Diethylcarbamazine (adverse effects), Diethylcarbamazine (supply & distribution), Drug Administration Schedule, Elephantiasis, Filarial (drug therapy), Elephantiasis, Filarial (economics), Elephantiasis, Filarial (prevention & control), Filaricides (administration & dosage), Filaricides (adverse effects), Filaricides (supply & distribution), Health Education (economics), Health Education (methods), Health Knowledge, Attitudes, Practice, Health Plan Implementation, Humans, India (epidemiology), Medication Adherence (statistics & numerical data), Medication Systems (organization & administration), Organizational Innovation, Program Development, Tablets.
- MESH :
- chemical , administration & dosage : Diethylcarbamazine, Filaricides.
- chemical , adverse effects : Diethylcarbamazine, Filaricides.
- drug therapy : Elephantiasis, Filarial.
- economics : Elephantiasis, Filarial, Health Education.
- education : Community Health Workers.
- epidemiology : India.
- manpower : Community Health Services.
- methods : Health Education.
- organization & administration : Community Health Services, Medication Systems.
- prevention & control : Elephantiasis, Filarial.
- statistics & numerical data : Medication Adherence.
- chemical , supply & distribution : Diethylcarbamazine, Filaricides.
- Adult, Child, Community Participation, Cross-Sectional Studies, Data Collection, Drug Administration Schedule, Health Knowledge, Attitudes, Practice, Health Plan Implementation, Humans, Organizational Innovation, Program Development, Tablets.
Abstract
The mass drug administration (MDA) is one of the strategies to eliminate lymphatic filariasis in India. Eleven districts are endemic for the disease in Madhya Pradesh state of India, which conduct MDA activities annually. A mid-term evaluation was conducted with the objectives to review the progress of the single dose of di-ethyl-carbamazine (DEC) administration, and to understand the functioning of the programme to recommend mid-term amendments.
PubMed: 19248659
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: Pour aller vers cette notice dans l'étape Curation :002F56
Links to Exploration step
pubmed:19248659Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.</title>
<author><name sortKey="Lahariya, Chandrakant" sort="Lahariya, Chandrakant" uniqKey="Lahariya C" first="Chandrakant" last="Lahariya">Chandrakant Lahariya</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Community Medicine, Gajra Raja Medical College and Associated Hospitals, Gwalior, India. ck1800@rediffmail.com</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Community Medicine, Gajra Raja Medical College and Associated Hospitals, Gwalior</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mishra, Ashok" sort="Mishra, Ashok" uniqKey="Mishra A" first="Ashok" last="Mishra">Ashok Mishra</name>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2008">2008</date>
<idno type="RBID">pubmed:19248659</idno>
<idno type="pmid">19248659</idno>
<idno type="wicri:Area/PubMed/Corpus">002F56</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">002F56</idno>
<idno type="wicri:Area/PubMed/Curation">002F56</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">002F56</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.</title>
<author><name sortKey="Lahariya, Chandrakant" sort="Lahariya, Chandrakant" uniqKey="Lahariya C" first="Chandrakant" last="Lahariya">Chandrakant Lahariya</name>
<affiliation wicri:level="1"><nlm:affiliation>Department of Community Medicine, Gajra Raja Medical College and Associated Hospitals, Gwalior, India. ck1800@rediffmail.com</nlm:affiliation>
<country xml:lang="fr">Inde</country>
<wicri:regionArea>Department of Community Medicine, Gajra Raja Medical College and Associated Hospitals, Gwalior</wicri:regionArea>
</affiliation>
</author>
<author><name sortKey="Mishra, Ashok" sort="Mishra, Ashok" uniqKey="Mishra A" first="Ashok" last="Mishra">Ashok Mishra</name>
</author>
</analytic>
<series><title level="j">Journal of vector borne diseases</title>
<idno type="ISSN">0972-9062</idno>
<imprint><date when="2008" type="published">2008</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Adult</term>
<term>Child</term>
<term>Community Health Services (manpower)</term>
<term>Community Health Services (organization & administration)</term>
<term>Community Health Workers (education)</term>
<term>Community Participation</term>
<term>Cross-Sectional Studies</term>
<term>Data Collection</term>
<term>Diethylcarbamazine (administration & dosage)</term>
<term>Diethylcarbamazine (adverse effects)</term>
<term>Diethylcarbamazine (supply & distribution)</term>
<term>Drug Administration Schedule</term>
<term>Elephantiasis, Filarial (drug therapy)</term>
<term>Elephantiasis, Filarial (economics)</term>
<term>Elephantiasis, Filarial (prevention & control)</term>
<term>Filaricides (administration & dosage)</term>
<term>Filaricides (adverse effects)</term>
<term>Filaricides (supply & distribution)</term>
<term>Health Education (economics)</term>
<term>Health Education (methods)</term>
<term>Health Knowledge, Attitudes, Practice</term>
<term>Health Plan Implementation</term>
<term>Humans</term>
<term>India (epidemiology)</term>
<term>Medication Adherence (statistics & numerical data)</term>
<term>Medication Systems (organization & administration)</term>
<term>Organizational Innovation</term>
<term>Program Development</term>
<term>Tablets</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Adulte</term>
<term>Agents de santé communautaire (enseignement et éducation)</term>
<term>Calendrier d'administration des médicaments</term>
<term>Collecte de données</term>
<term>Comprimés</term>
<term>Connaissances, attitudes et pratiques en santé</term>
<term>Diéthylcarbamazine (administration et posologie)</term>
<term>Diéthylcarbamazine (effets indésirables)</term>
<term>Diéthylcarbamazine (ressources et distribution)</term>
<term>Enfant</term>
<term>Filaricides (administration et posologie)</term>
<term>Filaricides (effets indésirables)</term>
<term>Filaricides (ressources et distribution)</term>
<term>Filariose lymphatique ()</term>
<term>Filariose lymphatique (traitement médicamenteux)</term>
<term>Filariose lymphatique (économie)</term>
<term>Humains</term>
<term>Inde (épidémiologie)</term>
<term>Innovation organisationnelle</term>
<term>Mise au point de programmes</term>
<term>Mise en oeuvre des programmes de santé</term>
<term>Observance du traitement médicamenteux ()</term>
<term>Participation communautaire</term>
<term>Services de santé communautaires (main d’œuvre)</term>
<term>Services de santé communautaires (organisation et administration)</term>
<term>Systèmes de distribution des médicaments (organisation et administration)</term>
<term>Éducation pour la santé ()</term>
<term>Éducation pour la santé (économie)</term>
<term>Études transversales</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="administration & dosage" xml:lang="en"><term>Diethylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="adverse effects" xml:lang="en"><term>Diethylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" qualifier="administration et posologie" xml:lang="fr"><term>Diéthylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" qualifier="drug therapy" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="economics" xml:lang="en"><term>Elephantiasis, Filarial</term>
<term>Health Education</term>
</keywords>
<keywords scheme="MESH" qualifier="education" xml:lang="en"><term>Community Health Workers</term>
</keywords>
<keywords scheme="MESH" qualifier="effets indésirables" xml:lang="fr"><term>Diéthylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" qualifier="enseignement et éducation" xml:lang="fr"><term>Agents de santé communautaire</term>
</keywords>
<keywords scheme="MESH" qualifier="epidemiology" xml:lang="en"><term>India</term>
</keywords>
<keywords scheme="MESH" qualifier="main d’œuvre" xml:lang="fr"><term>Services de santé communautaires</term>
</keywords>
<keywords scheme="MESH" qualifier="manpower" xml:lang="en"><term>Community Health Services</term>
</keywords>
<keywords scheme="MESH" qualifier="methods" xml:lang="en"><term>Health Education</term>
</keywords>
<keywords scheme="MESH" qualifier="organisation et administration" xml:lang="fr"><term>Services de santé communautaires</term>
<term>Systèmes de distribution des médicaments</term>
</keywords>
<keywords scheme="MESH" qualifier="organization & administration" xml:lang="en"><term>Community Health Services</term>
<term>Medication Systems</term>
</keywords>
<keywords scheme="MESH" qualifier="prevention & control" xml:lang="en"><term>Elephantiasis, Filarial</term>
</keywords>
<keywords scheme="MESH" qualifier="ressources et distribution" xml:lang="fr"><term>Diéthylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" qualifier="statistics & numerical data" xml:lang="en"><term>Medication Adherence</term>
</keywords>
<keywords scheme="MESH" type="chemical" qualifier="supply & distribution" xml:lang="en"><term>Diethylcarbamazine</term>
<term>Filaricides</term>
</keywords>
<keywords scheme="MESH" qualifier="traitement médicamenteux" xml:lang="fr"><term>Filariose lymphatique</term>
</keywords>
<keywords scheme="MESH" qualifier="économie" xml:lang="fr"><term>Filariose lymphatique</term>
<term>Éducation pour la santé</term>
</keywords>
<keywords scheme="MESH" qualifier="épidémiologie" xml:lang="fr"><term>Inde</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Adult</term>
<term>Child</term>
<term>Community Participation</term>
<term>Cross-Sectional Studies</term>
<term>Data Collection</term>
<term>Drug Administration Schedule</term>
<term>Health Knowledge, Attitudes, Practice</term>
<term>Health Plan Implementation</term>
<term>Humans</term>
<term>Organizational Innovation</term>
<term>Program Development</term>
<term>Tablets</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Adulte</term>
<term>Calendrier d'administration des médicaments</term>
<term>Collecte de données</term>
<term>Comprimés</term>
<term>Connaissances, attitudes et pratiques en santé</term>
<term>Enfant</term>
<term>Filariose lymphatique</term>
<term>Humains</term>
<term>Innovation organisationnelle</term>
<term>Mise au point de programmes</term>
<term>Mise en oeuvre des programmes de santé</term>
<term>Observance du traitement médicamenteux</term>
<term>Participation communautaire</term>
<term>Éducation pour la santé</term>
<term>Études transversales</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The mass drug administration (MDA) is one of the strategies to eliminate lymphatic filariasis in India. Eleven districts are endemic for the disease in Madhya Pradesh state of India, which conduct MDA activities annually. A mid-term evaluation was conducted with the objectives to review the progress of the single dose of di-ethyl-carbamazine (DEC) administration, and to understand the functioning of the programme to recommend mid-term amendments.</div>
</front>
</TEI>
<pubmed><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">19248659</PMID>
<DateCreated><Year>2009</Year>
<Month>03</Month>
<Day>02</Day>
</DateCreated>
<DateCompleted><Year>2009</Year>
<Month>03</Month>
<Day>17</Day>
</DateCompleted>
<DateRevised><Year>2016</Year>
<Month>11</Month>
<Day>24</Day>
</DateRevised>
<Article PubModel="Print"><Journal><ISSN IssnType="Print">0972-9062</ISSN>
<JournalIssue CitedMedium="Print"><Volume>45</Volume>
<Issue>4</Issue>
<PubDate><Year>2008</Year>
<Month>Dec</Month>
</PubDate>
</JournalIssue>
<Title>Journal of vector borne diseases</Title>
<ISOAbbreviation>J Vector Borne Dis</ISOAbbreviation>
</Journal>
<ArticleTitle>Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study.</ArticleTitle>
<Pagination><MedlinePgn>313-20</MedlinePgn>
</Pagination>
<Abstract><AbstractText Label="BACKGROUND & OBJECTIVES" NlmCategory="OBJECTIVE">The mass drug administration (MDA) is one of the strategies to eliminate lymphatic filariasis in India. Eleven districts are endemic for the disease in Madhya Pradesh state of India, which conduct MDA activities annually. A mid-term evaluation was conducted with the objectives to review the progress of the single dose of di-ethyl-carbamazine (DEC) administration, and to understand the functioning of the programme to recommend mid-term amendments.</AbstractText>
<AbstractText Label="METHODS" NlmCategory="METHODS">A qualitative cross-sectional study was conducted in three endemic districts of Madhya Pradesh between July and October 2007. The teams of faculty members from medical college visited the study districts and collected data by desk review, indepth interviews, on site observations, and from the community.</AbstractText>
<AbstractText Label="RESULTS" NlmCategory="RESULTS">The filaria units in these districts were understaffed. There were no night clinics in two out of the three districts. The sufficient number of trainings for MDA were conducted without any mechanism for quality assurance. There was erratic and inadequate supply of DEC tablets, leading to the postponement of MDA activity, twice. The evaluated coverage with DEC tablets was much lower than that reported by the district officials. The tablet intake was not ensured by the distributors and the compliance rate was in the range of 60-70%. The IEC activities were conducted in limited areas, and there were prevailing myths and misconceptions, contributing to low compliance rate. There was no proper recording of the data on filariasis with gross mismatch at district headquarters and peripheral health facilities. A proportion of community members developed side effects following DEC tablet intake and had to visit private health facilities for treatment.</AbstractText>
<AbstractText Label="INTERPRETATION & CONCLUSION" NlmCategory="CONCLUSIONS">This evaluation study noted that MDA is restricted to tablet distribution only and the major issues of implementation in compliance, health education, side effect and morbidity management, and the logistics were not being given due attention. The implementation should be strengthened immediately in the MDA programme in India to achieve the goal of LF elimination by 2015.</AbstractText>
</Abstract>
<AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Lahariya</LastName>
<ForeName>Chandrakant</ForeName>
<Initials>C</Initials>
<AffiliationInfo><Affiliation>Department of Community Medicine, Gajra Raja Medical College and Associated Hospitals, Gwalior, India. ck1800@rediffmail.com</Affiliation>
</AffiliationInfo>
</Author>
<Author ValidYN="Y"><LastName>Mishra</LastName>
<ForeName>Ashok</ForeName>
<Initials>A</Initials>
</Author>
</AuthorList>
<Language>eng</Language>
<PublicationTypeList><PublicationType UI="D023362">Evaluation Studies</PublicationType>
<PublicationType UI="D016428">Journal Article</PublicationType>
<PublicationType UI="D013485">Research Support, Non-U.S. Gov't</PublicationType>
</PublicationTypeList>
</Article>
<MedlineJournalInfo><Country>India</Country>
<MedlineTA>J Vector Borne Dis</MedlineTA>
<NlmUniqueID>101212761</NlmUniqueID>
<ISSNLinking>0972-9062</ISSNLinking>
</MedlineJournalInfo>
<ChemicalList><Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D005369">Filaricides</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>0</RegistryNumber>
<NameOfSubstance UI="D013607">Tablets</NameOfSubstance>
</Chemical>
<Chemical><RegistryNumber>V867Q8X3ZD</RegistryNumber>
<NameOfSubstance UI="D004049">Diethylcarbamazine</NameOfSubstance>
</Chemical>
</ChemicalList>
<CitationSubset>IM</CitationSubset>
<MeshHeadingList><MeshHeading><DescriptorName UI="D000328" MajorTopicYN="N">Adult</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003153" MajorTopicYN="N">Community Health Services</DescriptorName>
<QualifierName UI="Q000364" MajorTopicYN="N">manpower</QualifierName>
<QualifierName UI="Q000458" MajorTopicYN="N">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003150" MajorTopicYN="N">Community Health Workers</DescriptorName>
<QualifierName UI="Q000193" MajorTopicYN="N">education</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003256" MajorTopicYN="N">Community Participation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003430" MajorTopicYN="N">Cross-Sectional Studies</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D003625" MajorTopicYN="N">Data Collection</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004049" MajorTopicYN="N">Diethylcarbamazine</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000600" MajorTopicYN="N">supply & distribution</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004334" MajorTopicYN="N">Drug Administration Schedule</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D004605" MajorTopicYN="N">Elephantiasis, Filarial</DescriptorName>
<QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000517" MajorTopicYN="N">prevention & control</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D005369" MajorTopicYN="N">Filaricides</DescriptorName>
<QualifierName UI="Q000008" MajorTopicYN="Y">administration & dosage</QualifierName>
<QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>
<QualifierName UI="Q000600" MajorTopicYN="N">supply & distribution</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006266" MajorTopicYN="N">Health Education</DescriptorName>
<QualifierName UI="Q000191" MajorTopicYN="N">economics</QualifierName>
<QualifierName UI="Q000379" MajorTopicYN="N">methods</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007722" MajorTopicYN="N">Health Knowledge, Attitudes, Practice</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006284" MajorTopicYN="N">Health Plan Implementation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D007194" MajorTopicYN="N">India</DescriptorName>
<QualifierName UI="Q000453" MajorTopicYN="N">epidemiology</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D055118" MajorTopicYN="N">Medication Adherence</DescriptorName>
<QualifierName UI="Q000706" MajorTopicYN="N">statistics & numerical data</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D008509" MajorTopicYN="N">Medication Systems</DescriptorName>
<QualifierName UI="Q000458" MajorTopicYN="Y">organization & administration</QualifierName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D009936" MajorTopicYN="N">Organizational Innovation</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D016730" MajorTopicYN="Y">Program Development</DescriptorName>
</MeshHeading>
<MeshHeading><DescriptorName UI="D013607" MajorTopicYN="N">Tablets</DescriptorName>
</MeshHeading>
</MeshHeadingList>
</MedlineCitation>
<PubmedData><History><PubMedPubDate PubStatus="entrez"><Year>2009</Year>
<Month>3</Month>
<Day>3</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="pubmed"><Year>2009</Year>
<Month>3</Month>
<Day>3</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
<PubMedPubDate PubStatus="medline"><Year>2009</Year>
<Month>3</Month>
<Day>18</Day>
<Hour>9</Hour>
<Minute>0</Minute>
</PubMedPubDate>
</History>
<PublicationStatus>ppublish</PublicationStatus>
<ArticleIdList><ArticleId IdType="pubmed">19248659</ArticleId>
</ArticleIdList>
</PubmedData>
</pubmed>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Sante/explor/LymphedemaV1/Data/PubMed/Curation
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 002F56 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd -nk 002F56 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Sante |area= LymphedemaV1 |flux= PubMed |étape= Curation |type= RBID |clé= pubmed:19248659 |texte= Strengthening of mass drug administration implementation is required to eliminate lymphatic filariasis from India: an evaluation study. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/PubMed/Curation/RBID.i -Sk "pubmed:19248659" \ | HfdSelect -Kh $EXPLOR_AREA/Data/PubMed/Curation/biblio.hfd \ | NlmPubMed2Wicri -a LymphedemaV1
![]() | This area was generated with Dilib version V0.6.31. | ![]() |